http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111548396-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20022 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56972 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70539 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
filingDate | 2020-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111548396-B |
titleOfInvention | Novel coronavirus T cell epitope peptide, pMHC, preparation and application thereof |
abstract | The invention discloses a novel coronavirus T cell epitope peptide, pMHC, and preparation and application thereof. The novel coronavirus T cell epitope peptide has an amino acid sequence shown in any one of SEQ ID NO 1-9. The invention discovers 9 novel coronavirus T cell epitope peptides, prepares a pMHC compound monomer by using the peptides, and further prepares a pMHC compound polymer which can be used for detecting antigen-specific T cells in peripheral blood of a novel coronavirus infection rehabilitee and used for in-vitro T cell activation experiments. |
priorityDate | 2020-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.